MedPath

Development of a new 3D virtual desktop imaging technique for real time non-invasive evaluation of the utero-placental interface vascularization throughout pregnancy.

Completed
Conditions
Placental development
10010273
Registration Number
NL-OMON44711
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
520
Inclusion Criteria

1) Women * 18 and 45 * years of age, planning a pregnancy or < 10 weeks pregnant.
2) Understanding of Dutch (Erasmus MC) in speaking and reading.
3) Willingness to be in the study for 1 month (PREC) and/or around 7 months (PREG) for the assessments using the VIRTUAL clinical prototype.
4) Willingness to give written informed consent.

Exclusion Criteria

1) Women unable or unwilling to give informed consent.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath